Redwood Scientific Technologies announced that, as of 11-13-2023 at 10:42 AM, it has secured conditional approval from the Institutional Review Board (IRB)/Central Institutional Review Board (CIRB). This milestone marks a significant advancement in Redwood's ongoing efforts towards clinical study work, aiming to develop and introduce an Oral Thin Film Strip to address nicotine addiction in vape devices. The conditional IRB approval not only paves the way for the study on Redwood's innovative product for nicotine addiction in vape devices but also extends to a study on TBX FREE, the company's primary product designed to combat nicotine addiction in traditional cigarettes.

Redwood envisions being the pioneer in the market with a nicotine-free solution for addiction to nicotine in e- vape devices. This conditional approval from IRB/CIRB signifies a crucial step forward for Redwood Scientific Technologies in its commitment to addressing nicotine addiction across various mediums. The company remains dedicated to accelerating the development and market availability of these solutions to make a meaningful impact on the current challenges associated with nicotine dependency.